The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...

Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...

If you have questions about how to use Zepbound, talk with your doctor or pharmacist. There’s also a helpful video and step-by-step instructions on the manufacturer’s website. Injection site ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity treatment market, according to a ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could ... drug insurance plan,” the drugmaker says on its web site. “If you have commercial drug insurance with coverage for Zepbound ...